|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Former Related Party | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income/(expense): | |||||
| Interest income | |||||
| Gain on investment in related party | |||||
| Interest and investment income | |||||
| Gain on investment in former related party | |||||
| Loss on currency exchange, net | |||||
| Other expense | |||||
| Total other income | |||||
| Net loss | |||||
| Other comprehensive income: | |||||
| Unrealized gain on marketable securities | |||||
| Total other comprehensive income | |||||
| Total comprehensive loss | |||||
| Net loss per share attributable to common stockholders, basic | |||||
| Net loss per share attributable to common stockholders, diluted | |||||
| Weighted-average number of shares of common stock outstanding including shares issuable under equity-classified pre-funded warrants, used in computing net loss per share of common stock, basic | |||||
| Weighted-average number of shares of common stock outstanding including shares issuable under equity-classified pre-funded warrants, used in computing net loss per share of common stock, diluted | |||||
Loading...